EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors Meeting Abstract


Authors: O'Donnell, P.; Galsky, M. D.; Rosenberg, J. E.; Petrylak, D. P.; Balar, A. V.; McGregor, B. A.; Heath, E.; Yu, E. Y.; Quinn, D. I.; Hahn, N. M.; Campbell, M.; Liang, S. Y.; Steinberg, J.; Loriot, Y.
Abstract Title: EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S579
End Page: S580
Language: English
ACCESSION: WOS:000573469101034
DOI: 10.1016/j.annonc.2020.08.818
PROVIDER: wos
Notes: Meeting Abstract: 746P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg